Last reviewed · How we verify
Placebo in combination with metformin — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo in combination with metformin (Placebo in combination with metformin) — Campus Bio-Medico University. Placebo has no active pharmacological mechanism; when combined with metformin, the therapeutic effect is entirely attributable to metformin's action on glucose metabolism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo in combination with metformin TARGET | Placebo in combination with metformin | Campus Bio-Medico University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo in combination with metformin CI watch — RSS
- Placebo in combination with metformin CI watch — Atom
- Placebo in combination with metformin CI watch — JSON
- Placebo in combination with metformin alone — RSS
Cite this brief
Drug Landscape (2026). Placebo in combination with metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-in-combination-with-metformin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab